Colgate-Palmolive (NYSE: CL) reported Q3 EPS of $0.91, $0.02 better than the analyst estimate of $0.89. Revenue for the quarter came in at $5.13 billion versus the consensus estimate of $5.13 billion.

Based on current spot rates and including the estimated impact of tariffs announced and finalized as of October 29, 2025:

The Company still expects net sales to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange.
The Company now expects organic sales growth to be 1% to 2%, roughly in line with year-to-date organic sales growth of 1.2%, versus at the low end of 2% to 4% previously. This includes an approximately 70 basis point impact from our exit from private label pet sales.
On a GAAP basis, the Company now expects gross profit margin to be roughly in line with year-to-date gross profit margin of 60.1% versus roughly flat previously, and still expects advertising to be roughly flat as a percentage of net sales and earnings per share to be up low single digits.
On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be roughly in line with year-to-date gross profit margin of 60.1% versus roughly flat previously, and still expects advertising to be roughly flat as a percentage of net sales and earnings per share to be up low single digits.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.